Kexin Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Kexin Li has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Jianing Sun
School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China
2 shared publicationsXin He
School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China
2 shared publicationsYizhen Yan
School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China
2 shared publicationsDezhen Fang
Key Laboratory of Comprehensive and Highly Efficient Utilization of Salt Lake Resources, Qinghai Institute of Salt Lakes, Chinese Academy of Sciences, Xining, Qinghai 810008, PR China
1 shared publication- Haining Liu
Key Laboratory of Green and High-End Utilization of Salt Lake Resources, Key Laboratory of Salt Lake Resources Chemistry of Qinghai Province, Qinghai Institute of Salt Lakes, Chinese Academy of Sciences, Xining 810008, China
1 shared publication Hekai Pang
School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China
1 shared publication
Latest Publications
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in Materials Chemistry Frontiers
Co-administration of dual ZIF-90-based nanoparticles for hypoxic tumor microenvironment reprogramming to enhance chemo-photodynamic therapy
Dual ZIF-90-based nanoparticles combine hypoxic TME reprogramming with multimodal chemo-photodynamic therapy to overcome hypoxia-associated limitations of oxygen-dependent antitumor therapies.
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in Materials Chemistry Frontiers
Co-administration of dual ZIF-90-based nanoparticles for hypoxic tumor microenvironment reprogramming to enhance chemo-photodynamic therapy
Dual ZIF-90-based nanoparticles combine hypoxic TME reprogramming with multimodal chemo-photodynamic therapy to overcome hypoxia-associated limitations of oxygen-dependent antitumor therapies.
- 28 December 2025
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 690, 126540
An intelligent responsive ZIF-8 co-delivery nanoplatform with multimodal synergistic technologies for closed-loop therapy of tumors
- 28 December 2025
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 690, 126540
An intelligent responsive ZIF-8 co-delivery nanoplatform with multimodal synergistic technologies for closed-loop therapy of tumors
- Open Access
- 27 October 2023
- Published by Royal Society of Chemistry (RSC) in Materials Chemistry Frontiers
- Vol. 8 (5) , 1195-1211
Research advances and applications of ZIF-90 metal–organic framework nanoparticles in the biomedical field
A schematic illustration of ZIF-90 nanocomposites applied to anticancer therapy, biomedical imaging and other fields for the treatment of different diseases.
- 27 October 2023
- Published by Royal Society of Chemistry (RSC) in Materials Chemistry Frontiers
- Vol. 8 (5) , 1195-1211
Open AccessResearch advances and applications of ZIF-90 metal–organic framework nanoparticles in the biomedical field
A schematic illustration of ZIF-90 nanocomposites applied to anticancer therapy, biomedical imaging and other fields for the treatment of different diseases.